“…A much larger number of patients might suffer from vague symptoms and are therefore not being diagnosed with post-gastric bypass hypoglycemia. Subsequently, they are not offered adequate treatment, which might consist of dietary modifications [18,28], acarbose [29][30][31], octreotide [15,32], verapamil [33] or diazoxide [34] as drug therapy or surgical interventions such as secondary bypass banding [35,36], bypass reversal [37,38] or pancreatic resection [24][25][26][27]39]. In our study, CGM provided better detection rates for post-RYGB hypoglycemia compared with MMT.…”